Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hoepner

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Multiple Sclerosis and Related Disorders|July 27, 2023
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Human Brain Mapping|June 8, 2026
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness EstimatesTimo Blattner, David Romascano, Richard McKinley, et al.
Epilepsy & Behavior : E&B|March 2, 2012
Unilateral autoscopic phenomena as a lateralizing sign in focal epilepsyRobert Hoepner, Kirsten Labudda, Matthias Hoppe, et al.
Vaccines|June 24, 2022
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis PatientsHelly Hammer, Robert Hoepner, Christoph Friedli, et al.
Journal of Travel Medicine|October 9, 2025
Viable Schistosoma mansoni infection 41 years after last exposure-a case report of a loyal parasiteCornelia Staehelin, Anna Eichenberger, Aart Mookhoek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 16, 2020
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective studyLara Diem, Ariadne Daponte, Oliver Findling, et al.
Therapeutic Advances in Neurological Disorders|April 9, 2019
Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre studyAndrei Miclea, Anke Salmen, Roland Wiest, et al.
Frontiers in Neurology|October 16, 2018
Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS DisordersFranca Wagner, Lorenz Grunder, Arsany Hakim, et al.
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Human Brain Mapping|October 17, 2022
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosisMichael Rebsamen, Richard McKinley, Piotr Radojewski, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis and Related Disorders|July 27, 2023
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Human Brain Mapping|June 8, 2026
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness EstimatesTimo Blattner, David Romascano, Richard McKinley, et al.
Epilepsy & Behavior : E&B|March 2, 2012
Unilateral autoscopic phenomena as a lateralizing sign in focal epilepsyRobert Hoepner, Kirsten Labudda, Matthias Hoppe, et al.
Vaccines|June 24, 2022
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis PatientsHelly Hammer, Robert Hoepner, Christoph Friedli, et al.
Journal of Travel Medicine|October 9, 2025
Viable Schistosoma mansoni infection 41 years after last exposure-a case report of a loyal parasiteCornelia Staehelin, Anna Eichenberger, Aart Mookhoek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 16, 2020
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective studyLara Diem, Ariadne Daponte, Oliver Findling, et al.
Therapeutic Advances in Neurological Disorders|April 9, 2019
Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre studyAndrei Miclea, Anke Salmen, Roland Wiest, et al.
Frontiers in Neurology|October 16, 2018
Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS DisordersFranca Wagner, Lorenz Grunder, Arsany Hakim, et al.
Therapeutic Advances in Neurological Disorders|March 27, 2024
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse eventsPauline Thränhardt, Admirim Veselaj, Christoph Friedli, et al.
Human Brain Mapping|October 17, 2022
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosisMichael Rebsamen, Richard McKinley, Piotr Radojewski, et al.
Pageof 13